Overview
- 7 inspections across 7 sites are on record.
- 7 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-02-04.
At a glance
Inspections
7
Sites
7
Observations
7
Career since
Mar 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Janssen Research & Development, LLC | 4 Feb 2019 | Human Drugs | |
| IQVIA | 30 Jan 2019 | Human Drugs | |
| Madhukar H. Trivedi, MD | 11 Jan 2019 | Human Drugs | View 483 → |
| Lubos Janu, MD | 14 Dec 2018 | Human Drugs | |
| Aradigm Corporation | 24 Jan 2018 | Human Drugs |
Sites inspected
Janssen Research & Development, LLCTitusville, United States1 insp.
IQVIADurham, United States1 insp.
Madhukar H. Trivedi, MDDallas, United States1 insp.
Lubos Janu, MDPlzen 12, Czech Republic1 insp.
Aradigm CorporationHayward, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Bei Yu1 shared
Camille D Brown1 shared
Shirley S Wen1 shared
Eileen J Bannerman1 shared
Laree A Tracy1 shared
Thea C Grome1 shared
Gene R Gunn1 shared
Daniel J Roberts1 shared
Susan D Yuscius1 shared
Debra L Boyd Seale1 shared
Full investigator report
Get the verbatim findings behind Mathew T Thomas' 7 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site